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ABSTRACT
Objectives: Induction of labour is one of the most common procedures used in obstetrics and its prevalence tends to 
increase. In patients with an unripe cervix (Bishop score < 7) pre-induction procedures are used before the start of oxytocin 
induction. Currently there is no consensus among scientific societies on the optimal way of pre-induction. We have con-
ducted a single-centre retrospective observational study comparing obstetric induction results of patients after 37 weeks 
of gestation who were pre-induced with misoprostol vaginal insert (MVI) with 200 µg of misoprostol (Misodel — Ferring 
Pharmaceuticals Poland) or Foley catheter (20 F, 60 mL baloon). 
Material and methods: We have reviewed the medical records of 503 patients (group A pre-induced MVI — 135 patients, 
group B pre-induced Foley catheter — 368 patients) who were in a single, full-term pregnancy, pre-induced due to unripe 
cervixes (Bishop score < 7) with a Foley catheter or Misodel (MVI 200 µg). We compared obstetric results between groups. 
Results: Group A patients had a lower chance of using oxytocin in labour induction/augmentation (OR = 0.21 95% 
CI = 0.13–0.32), and a greater chance of surgical delivery by caesarean section (OR = 2.14 95% CI = 1.42–3.23) and vacuum 
extraction (OR = 3.29 95% CI = 1.08–10.00). Group A patients also had a greater chance of abnormal CTG (OR = 2.66 95% 
CI = 1.5–4.7) compared to group B. The groups did not differ in terms of meconium stained amniotic fluid and postpartum 
haemorrhage. The percentage of children born with a pH from umbilical cord blood < 7.2 and < 7.1 and newborns of 
medium general condition (Apgar 4–7) did not differ between the groups.
Conclusions: Neonatological results of children from Foley catheters and MVI induced delivery do not differ. Patients 
pre-induced with MVI rarely require labour augmentation with oxytocin. MVI-preinduced patients have a better chance of 
having a delivery by CS or VE compared to the Foley catheter. 
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INTRODUCTION 
Induction of labour (IOL) is a procedure whose preva-
lence varies dramatically from country to country and may 
range from 1.4% to 35.5% [1]. In countries with high levels of 
economic development, it is used in about 1 in 5 pregnant 
women after the 37th week of pregnancy [2]. It is undoubt-
edly a procedure reducing the mortality and morbidity 
of newborns and pregnant women in the case of specific 
complications in pregnancy and should be used when, in 
the opinion of the clinician, the risk associated with wait-
ing for spontaneus onset of labour is greater than the risks 
associated with shortening the duration of pregnancy by 
IOL. It seems to be generally accepted that for unripe cer-
vix (usually defined by Bishop score < 7) cervical ripening 
(pre-induction of labour) is necessary. At present, there is 
no consensus among scientific societies in the world on the 
optimal method of IOL, and the differences in local recom-
mendations mainly concern cervical ripening methods due 
to their diversity.
Objectives
Comparison of obstetric results of patients pre-induced 
with misoprostol vaginal insert which contains 200 µg of 
misoprostol slowly released 7 µg/hour for 24 hours (Misodel 
— Ferring Pharmaceuticals Poland) with patients in whom 
a Foley catheter was used to pre-induce labour. (20 F, 60 mL).
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MATERIAL AND METHODS
We reviewed the medical records of 503 patients who 
delivered in the Department of Gynecology and Obstet-
rics of the Provincial Hospital Complex in Kielce between 
4.03.2017 and 21.07.2018. All labours were induced. Indica-
tions for labour induction were in accordance with the rec-
ommendations of the Polish Society of Gynaecologists and 
Obstetricians [3]. The study included patients with single, 
full-term pregnancy (completed 37 weeks of pregnancy) 
who had unripe cervixes (Bishop score < 7) at the time of 
the decision on labour induction. MVI 200 (misoprostol vagi-
nal insert with 200 micrograms of misoprostol) — (group 
A — 135 patients) or Foley catheter (group B — 368 patients) 
20 F thick with 60 mL of saline balloon filling were used for 
labour pre-induction. Patients were sent to the delivery 
room at the start of regular contraction and cervical dilation 
of 3–4 cm or 20–24 hours after pre-induction in the absence 
of the start of labour. Oxytocin was used for induction and 
labour stimulation in a low-dose protocol, at 4–6 cm dilation 
amniotomy was performed. The groups were compared 
for obstetric results: — Apgar scores in one minute, pH 
from venous cord blood — in quantitative terms, as well 
as the percentage of children born with pH < 7.2 and < 7.1. 
We compared the percentage of meconium stained am-
niotic fluid (MSAF), surgical deliveries [vacuum extraction 
(VE) and cesarean section (CS)], postpartum haemorrhage 
(PPH), and the duration of stay in the delivery room. We per-
formed the statistical analysis using Statistica 13.1 (StatSoft 
Poland). For continuous variables we presented the arithme-
tic mean when the distribution was close to normal and as 
a median for skewed distributions. Standard deviation and 
interquartile range were used as measures of scatter, respec-
tively. We compared the groups when the assumptions of 
near-normal distribution and equal variance were met with 
the Student’s t-test, and when the above-mentioned criteria 
were not met with the Kruskallis-Wallis U test. In case of 
qualitative variables, we presented the data as a percentage 
of events in a given group and the quotient of chances of 
group A vs. B (OR), and compared the groups using Pearson’s 
χ2 test, and in case of small expected numbers we used 
Yates correction. The differences were considered statisti-
cally significant in case of p < 0.05. 
RESULTS 
The demographic characteristics of the groups were 
presented in Table 1.
The groups did not differ in terms of age, fertility, me-
dian gestational age and the percentage of patients who 
received epidural analgesia. The Foley catheter was not used 
for patients with pre-labour rapture of membranes (PROM). 
In group A, the percentage of patients with amniotic fluid 
drainage prior to MVI insertion was 17.05% (23 patients). 
The total percentage of CS was 32% and VE 2.5%. 
The results of the comparison of groups A and B are 
presented in Table 2.
Among patients in group A compared to group B, oxyto-
cin was used significantly less frequently in the stimulation 
or induction of labour [26% vs 62% (p < 0.001, OR = 0.21 95% 
Table 1. Characteristics of groups
A (n = 135) B (n = 368)
age [years] (mean ± SD) 27.5 ± 4.15 28.37 ± 4.72 p = 0.43
pluripara 17.78% 20.92% p = 0.48
gestational age (median, 
IQR) 40 (0.8) 40 (0.8) p = 0.93
Membranes rapture before 
pre-induction 17.05% 0% p < 0.01
epidural analgesia 15% 21% p = 0.06
SD — standard deviation; IQR — interquartile range
Table 2. Comparison of groups
A (n = 135) B (n = 368) p OR (95% CI)
oxitocin stimulation/induction 26% 62% p < 0.001 0.21 (0.13–0.32)
time at delivery room [h] (median, IQR) 8.75 (7.83) 8.16 (5.58) p = 0.13 N/A
cesarean section 45.19% 27.72% p < 0.001 2.14 (1.42–3.23)
unreassuring fetal heart rate pattern 24.55% 10.88% p < 0.001 2.66 (1.5–4.7)
arrested labour and failed induction 19.26% 13.59% p = 0.11 1.51 (0.90–2.55)
vacuum extraction 5.19% 1.63% p = 0.02 3.29 (1.08–10.00)
postpartum haemorrhage 2.22% 2.17% p = 0.97 1.02 (0.26–3.19)
meconium stained amniotic fluid 12.59% 12.50% p = 0.97 1.00(0.55–1.82)
pH (median, IQR) 7.358 (0.085) 7.374 (0.068) p < 0.01 N/A
pH < 7.2 3.70% 2.17% p = 0.33 1.73 (0.55–5.38)
pH < 7.1 0% 0% N/A N/A
Apgar 4–7 points 2.96% 1.63% p = 0.34 1.83 (0.51–6.61)
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CI = 0.13–0.32)]. Considering only the patients and groups 
A and B, whose labour ended in natural ways, the differ-
ence is similar (28.3% vs. 67.67%, p < 0.001, OR = 0.18 95% 
CI = 0.10–0.33). Patients pre-induced with MVI compared 
to the group pre-induced with Foley catheter had a signifi-
cantly higher chance of completion of labour through CS 
(OR = 2.14 95% CI 1.42–3.23) as well as VE (OR = 3, 29.95% 
CI = 1.08–10), the most common indication for operative 
labour in group A was nonreassuring fetal heart rate trac-
ing, which was statistically more frequent in comparison 
to group B (OR = 2.66 95% CI = 1.5–4.7). Among patients in 
group A and B who gave birth by nature the chance for VE 
was more than 5 times higher (9.46% vs 1.88%, p = 0.001, 
OR = 5.45 95% CI = 1.62–17.72). Groups A and B did not 
differ in terms of the most frequent indication for opera-
tive delivery, i.e. incorrect fetal CTG recording as well as 
frequency of MSAF and PPH. The median pH in group 
A was significantly lower, although both values were within 
the norm range (7.35 vs 7.37 p = 0.008), groups A and B 
did not differ in terms of the percentage of newborns born 
with pH < 7.2 and < 7.1. Patients in groups A and B did not 
differ in terms of the time they spent in the delivery room. 
In the whole study group, there were no newborns born 
in severe condition (defined as Apgar scores in 1 minute 
of life ≤ 3). Therefore, we compared groups in terms of the 
percentage of newborns born in general medium condition 
(Apgar 4–7 points in 1 minute), the groups did not differ 
significantly. 
DISCUSSION
Although induction of labor (IOL) is one of the most com-
mon interventions in obstetrics, the proportion of patients 
who will undergo this procedure may increase significantly 
in the coming years. Post-term pregnancy is one of the most 
common indications for induction of labour. The practice 
of post-term induction differs between countries [4], but 
usually in low-risk pregnancies this procedure is not used 
until the 41st week of pregnancy. A multi-centre random-
ized study published in 2018 indicates that induction of 
a low-risk pregnancy at 39th week of pregnancy may reduce 
the percentage of caesarean sections, hypertension-related 
pregnancy complications, improve patient satisfaction and 
through the reduction of pain without compromising neo-
natal outcomes [5]. Following the results of the this ARRIVE 
study [5]. The Society for Maternal-Fetal Medicine concluded 
that it is reasonable to offer elective induction to low-risk 
nulliparous women who are ≥ 39 + 0 weeks of gestation [6]. 
In the year preceding the publication in the United States, 
delivery after the 41st week of gestation concerned about 7% 
of pregnancies, and between 40 and 41 weeks of gestation 
about 25% of pregnancies [7]. The implementation of the 
results of the ARRIVE study into clinical practice may result 
in a significant increase in the IOL percentage in the future, 
through additional qualification for induction of labour of ap-
proximately 30% of pregnant women. Additional factors like 
increasing population rate of obesity and age of procreation 
will also take their role in this process [8]. Due to the large 
scale of the problem, research is needed to optimize the 
entire process of IOL in terms of woman and child safety as 
well as cost-effectiveness. One of the pre-induction methods 
used in patients with an unripe cervix is MVI. It is a therapeu-
tic system applied to the posterior vaginal vault releasing 
misoprostol (prostaglandin E1 analogue — PGE1) at a dose of 
about 7 µg per hour for a period of 24 hours (the total dose of 
misoprostol is 200 µg). The unquestionable advantage of the 
preparation is the ease of removal in the case of complications 
occurring during the application and the possibility of use 
at the outflow of amniotic fluid, moreover, the preparation 
is registered from the end of 36 weeks of pregnancy. MVI is 
removed from the vagina at the beginning of labour or at 
4 cm cervical dilation, 30 minutes after the removal of the 
preparation, an infusion of oxytocin can be started. In the 
Phase 3 key study for product registration, the product was 
used in patients [9] in whom cervical maturity was assessed 
to be 4 or less on the Bishop scale. There are no studies in the 
literature that directly compare the efficacy and obstetric per-
formance of Foley catheter-induced patients to MVI, but there 
are studies to evaluate other forms of misoprostol in IOL. The 
2016 meta-analysis showed that vaginal use of misoprostol 
tablets (compared to Foley catheter, vaginal dinoprostone 
and oral misoprostol) is associated with the highest chance 
of vaginal delivery within 24 hours and the highest risk of 
uterine hyperstimulation and abnormal CTG recording [10]. 
The main advantage of MVI is its ease of removal in case of 
the above-mentioned complications. The risk of developing 
hyperstimulation in a patient pre-induced with MVI is about 
13% and is one of the most common complications [9]. One 
of the studies [11] to analyze the use of MVI for pharmacoeco-
nomic purposes used an indirect comparison of MVI with the 
Foley catheter for prenatal pre-induction in accordance with 
Bucher’s method [12]. In the study cited, dinoprostone vagi-
nal insert (DVI — 10 mg of dinoprostone in insert releasing 
0.3 mg/h —Propess, Cervidil) was the common comparator. 
The median time needed to achieve active phase of labour 
with MVI was 44% lower than with Foley catheter (95% CI 
33.5–54.3%), there were no differences in the percentage 
of patients who gave birth vaginally, percentage of CS , fre-
quency of PPH, MSAF and chorioamnionitis. In the group of 
MVI pre-induced patients, less frequent prenatal oxytocin 
before delivery was used (RR = 0.5 95% CI 0.39–0.62). The risk 
of tachysystole was almost 40 times higher compared to the 
Foley catheter (RR = 39.91 95% CI = 5.02–317.5) [11]. In our 
cohort of patients, these correlations were similar, the chance 
of using oxytocin was about 5 times lower in the group of 
703
Jakub Mlodawski et al., MVI 200 µg vs. Foley catheter in labour pre-induction
www. journals.viamedica.pl/ginekologia_polska
patients who were pre-induced with MVI compared to those 
pre-induced with Foley catheter, this regularity applied both 
to patients who gave birth vaginally and to those who had 
a CS. The limitation of our study involves the lack of data about 
induction to delivery time (ID — time), it only includes the 
time the patient spent in the delivery room, which did not 
differ significantly. This value is less useful especially in the 
context of cost-effectiveness studies. The Expadite random-
ized study [9] comparing MVI with DVI revealed no differences 
in the percentage of caesarean sections between groups and 
the percentage of CS in the MVI group was 26%. However, ob-
servational studies in the Polish population indicate a higher 
percentage of CS. In one of the works in the Polish cohort 
of patients published by Jagielska et al. [13] the percentage 
of caesarean sections was 40.58% in the primagravida and 
16.13% in the plurigravida group, and the overall percentage 
of caesarean sections in the group of patients induced by MVI 
was 33%, which is lower than in our cohort. However, in the 
study cited above [12], the proportion of plurigravidas to the 
primagravidas in the studied group (31/69 = 0.45) was higher, 
and in our studies it was lower (24/111 = 0.21), (p = 0.018). Nu-
merous studies show that vaginal childbirth in the history is 
one of the strongest predictive factors of induction efficiency 
and occurs in most of the predictive models published in the 
literature [14, 15]. In our opinion, this proportion is crucial if 
we want to compare the percentage of caesarean sections 
between individual studies. This study demonstrates the high 
effectiveness of misoprostol in the form of MVI as the only 
method without the need to augment the delivery, however, 
the higher risk of surgical delivery compared to Foley catheter 
brings some concern. Clinical and biochemical condition of 
newborns did not differ significantly between groups. The 
question remains open whether this situation was influenced 
by the increased number of obstetric interventions (CS and 
VE) undertaken by supervising obstetricians. The limitation 
of the study is also related to the lack of division of patients 
according to the indications for induction of labour. 
CONCLUSIONS
Neonatological results of children from births induced with 
Foley catheter and MVI 200 do not differ.
Patients pre-induced with MVI 200 less frequently require 
oxitocin augumentation of labor.
MVI 200 pre-induced patients have a greater chance of 
delivery by CS and VE compering to patients pre-induced with 
Foley catheter.
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